Answers are grounded in this paper and cite their sources.
Aluminum is currently the most commonly used vaccine adjuvant. Toxicity and safety in regards to the use of aluminum adjuvants is highly controversial and also confused by conflicting study results. In general, it is regarded as safe by the pharmaceutical industry and the various regulatory agencies. Nevertheless, aluminum is a well demonstrated toxin in biological systems and its specific impacts on the nervous system have been widely documented. In regulatory preclinical studies, one of the co-authors has consistently identified the well-known local reaction granuloma. Except for granulomas at the injection site, other findings have not been observed in the course of the histopathologic evaluation. There were no indictors of neurotoxicity neither lesion in susceptible organs including the bone or immune system, nor indications for a general intoxication that could be related to exposure with aluminum hydroxide. However, other studies with various animal models have reported aluminum hydroxide to induce motor deficits, motor degeneration and neuro inflammation. A recent technology, taking advantage of fluorescent nano diamonds, that allows aluminum hydroxide particles to be traced in tissue have shown the progressive shrinkage of the local granuloma and the translocation of aluminum from the injection site to draining lymph nodes, spleen and brain tissue. Further it demonstrated differences between strains, doses, route of administration and injection site. Thus, these parameters should be taken into account in design for future preclinical models.
No takes yet. Share an insight, caveat, or question.
Nils Warfving (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: